Zyla Life Sciences (fka ZCOR)

[realfast95]

The key to this Quarter earnings is impact of this June press release.

Egalet Announces ARYMO® ER Added to Large Payer Formulary

http://egalet.investorroom.com/2017-06-06-Egalet-Announces-ARYMO-R-ER-Added-to-Large-Payer-Formulary

I have not found who this payer is. If the press release means EGLT products are on the radar. Then I did find it. However I have not found anywhere that they are the Preferred vendor over their main competitors. And that they would need written permission from the Doctor to the Payer.

For example Cigna
https://www.cigna.com/pdf/2017-prescription-drug-list-changes.pdf
searching for ARYMO
it appears in the Non-preferred brand medication column
And 3 competitors appear in the Preferred column
they are

Hysingla - Purdue
Oxycontin - Purdue
Xtampza - Collegium Pharmaceutical $COLL